BioSpace News Archive

Business

Biotech Startup Formed by 4 Ex-Pfizer Employees Inks Deal With Former Employer

The companies will collaborate on research to study a previously unrecognized role for peripheral immune cells in the pathology of central nervous system disorders.

January 23, 2018
·
2 min read
·
Alex Keown
Biotech Bay

Amarantus Subsidiary Cutanogen Corporation Announces Issuance of U.S. Patent 14/299

Once approved, ESS is eligible for 12 years of market exclusivity under the BPCIA.

January 23, 2018
·
6 min read
Genetown

Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock

The offering is expected to close on or about January 25, 2018, subject to customary closing conditions.

January 23, 2018
·
5 min read
Drug Development

Puma Sinks After the CHMP Throws a Roadblock at Breast Cancer Drug

The negative trend vote from the CHMP will likely mean the EMA will not authorize neratanib for extended adjuvant treatment of early-stage HER2-positive breast cancer.

January 23, 2018
·
2 min read
·
Alex Keown
Deals

Top 3 Takeover Targets for Pfizer

The year is already off to a good start with mergers and acquisitions in the biopharma industry.

January 23, 2018
·
3 min read
·
Mark Terry
Deals

Gilead’s Kite Pays $135M for Ex-Agensys R&D Building

The latest acquisition makes it the highest amount paid for a flex R&D building in Los Angeles County.

January 23, 2018
·
1 min read
Policy

Top Trends Impacting Biopharma Innovation Strategy in 2018

Significant risk remains for companies that cannot move quickly enough to positively impact R&D productivity and for those that encounter challenges in accessing technology and expertise that likely lie outside their organization.

January 23, 2018
·
4 min read
·
Elizabeth Iorns, BioSpace.com Contributor
BioCapital

Senate Vote to End Government Shutdown Suspends Medical Device Tax

The first payments would have been due by Jan. 29, 2018.

January 23, 2018
·
1 min read
Biotech Bay

3 Biotechs That Have Doubled Investors’ Money in Less Than a Year

Having a stock double in value is a good thing.

January 23, 2018
·
3 min read
·
Mark Terry
Pharm Country

New Kid Tmunity Banks $100M From Gilead and Facebook Billionaire Sean Parker

The funds raised will partly go towards funding two clinical trials that have already opened.

January 23, 2018
·
3 min read
·
Mark Terry